| PERIOD ENDING | 2-May-09 | 31-Jan-09 | 1-Nov-08 | 2-Aug-08 | | Total Revenue | 3,638,000 | 5,235,602 | 3,803,649 | 3,725,490 | | Cost of Revenue | 2,270,000 | 3,413,387 | 2,380,852 | 2,250,552 | | | Gross Profit | 1,368,000 | 1,822,215 | 1,422,797 | 1,474,938 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 961,000 | 1,101,978 | 981,455 | 929,821 | | Non Recurring | 15,000 | 4,701 | 20,512 | 5,887 | | Others | 141,000 | 142,851 | 135,491 | 132,681 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 251,000 | 572,685 | 285,339 | 406,549 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 21,000 |
-
|
-
| | Earnings Before Interest And Taxes | 251,000 | 593,685 | 285,339 | 406,549 | | Interest Expense | 32,000 | 50,544 | 28,265 | 26,493 | | Income Before Tax | 219,000 | 543,141 | 257,074 | 380,056 | | Income Tax Expense | 82,000 | 207,268 | 96,917 | 144,041 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 137,000 | 335,873 | 160,157 | 236,015 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 137,000 | 335,873 | 160,157 | 236,015 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $137,000 | $335,873 | $160,157 | $236,015 |
|
0.45% Nasdaq 
0.20%
Income Statement
